We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Graphene-Based Biosensors Could Detect Sepsis Earlier in Critically Ill Patients

By LabMedica International staff writers
Posted on 09 Jun 2023

Lactate serves as a vital biomarker in managing hospitalized patients who are critically ill. More...

A common complication in intensive care units, hyperlactatemia, can occur either due to insufficient oxygen supply to tissues or underlying conditions such as advanced liver disease. If left untreated, hyperlactatemia can escalate into lactate acidosis, a severe condition that can be life-threatening. Reliable real-time lactate detection, whether via single-point or continuous monitoring, has the potential to enhance patient outcomes in critical care and speed up the diagnosis of sepsis in critically ill individuals. Now, a new study has highlighted the significant potential of graphene-based biosensors for detecting elevated lactate levels.

The study by researchers at the University of Bath (Bath, UK) showed that using Integrated Graphene’s (Stirling, UK) Gii-Sens electrochemical sensor can enhance the diagnostic accuracy of hyperlactatemia. The Gii-Sens, a diagnostic biosensing electrode, outperforms conventional sensing materials by a factor of 10-100, enabling rapid, laboratory-quality testing at the point of need in a cost-effective manner. Gii-Sens electrochemical electrodes, produced using Integrated Graphene’s novel 3D graphene Gii, are disposable sensors designed for one-step assays without the need for pre-treatments.

“Lactate is a naturally occurring biomarker which everyone produces as a byproduct of exercising. For most people it is easily processed by the body and will cause no major harm, apart from a little cramp if you overexert yourself,” said Dr. Marco Caffio, Integrated Graphene’s Co-Founder and CSO. “However, for some critically ill patients and those with underlying conditions it can be a sign of a range of other issues, some of which, like sepsis, can be fatal. Having a robust way of monitoring lactate levels is important in ensuring the best possible outcomes for these patients. The findings of this study demonstrate Gii’s reliable performance and potential to save lives.”

Related Links:
University of Bath 
Integrated Graphene 


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Chromogenic Culture System
InTray™ COLOREX™ ECC
Benchtop Thermomixer
Biometra TS1 ThermoShaker
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The blood-based assay captures circulating chromatin, cell-free DNA fragments that are largely inaccessible through standard laboratory methods (image credit: Shuttertstock)

Blood-Based Assay Enables Noninvasive Monitoring of Sarcoma Immunotherapy Response

Sarcomas remain difficult to monitor during immunotherapy, as low tumor mutation burden can limit traditional circulating tumor DNA approaches and repeat tissue biopsies are often impractical in advanced disease.... Read more

Immunology

view channel
Image: New research shows that autoimmunity drives debilitating long COVID symptoms in a subset of patients (Image credit: Shutterstock)

Study Points to Autoimmune Pathway Behind Long COVID Symptoms

Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.